1.
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life. Bleeding Thromb Vascul Biol [Internet]. 2024 Apr. 22 [cited 2025 May 28];3(1). Available from: https://www.btvb.org/btvb/article/view/104